Osaic Holdings
TPTX

Osaic Holdings’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Osaic Holdings’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-447
Closed -$34K – 7769
2022
Q2 		$34K Sell
447
-51
-10% -$2.27K ﹤0.01% 5246
2022
Q1 		$14K Sell
498
-335
-40% -$11.3K ﹤0.01% 5960
2021
Q4 		$40K Buy
833
+109
+15% +$4.87K ﹤0.01% 5317
2021
Q3 		$48K Buy
724
+39
+6% +$2.78K ﹤0.01% 5152
2021
Q2 		$53K Buy
685
+21
+3% +$1.55K ﹤0.01% 5006
2021
Q1 		$62K Buy
664
+207
+45% +$24.6K ﹤0.01% 4726
2020
Q4 		$56K Buy
457
+144
+46% +$15.8K ﹤0.01% 4481
2020
Q3 		$28K Buy
313
+107
+52% +$7.45K ﹤0.01% 4714
2020
Q2 		$13K Buy
206
+188
+1,044% +$10.8K ﹤0.01% 5065
2020
Q1 		$1K Buy
+18
New +$956 ﹤0.01% 5986

Osaic Holdings's TPTX Position: Q3 2022 in Review

Osaic Holdings sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 447 shares — an estimated $34K sold.

Osaic Holdings first reported a position in TPTX in Q1 2020 and held it in 10 quarters. The position peaked at $62K in Q1 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Osaic Holdings reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Osaic Holdings sold 447 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $34K.
  • Osaic Holdings first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Osaic Holdings's Turning Point Therapeutics, Inc. Common Stock position peaked at $62K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.